EXPM:ZSANQ - Post Discussion
Post by
Humanist on Jul 02, 2019 3:01pm
zsan presentation at AMecian heache society july 13th
Zosano Pharma Announces Upcoming Presentation at American Headache Society Annual Meeting July 01, 2019 16:05 ET | Source: Zosano Pharma Corporation FREMONT, Calif., July 01, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that a poster and e-poster describing Migraine-ACT scores, or measures of patient satisfaction with the management of their migraines, following Qtrypta™ therapy used over 6-12 months will be presented at the American Headache Society (AHS) 61st Annual Scientific Meeting. The meeting will be held July 11-14, 2019 in Philadelphia. | Presentation Title: | Assessing the Long-Term Effectiveness of Qtrypta using the Migraine-ACT; Correlation with Electronic Diary Scores |
| Presenter: | Stewart J. Tepper, M.D., Dartmouth-Hitchcock Medical Center |
| Poster Number: | P230LB |
| | |
| e-Poster Presentation: | |
| Date and Time: | July 13, 2019 1:00 p.m. |
| Location: | Room 6 in Hall A, Pennsylvania Convention Center |
All posters will be on display from July 11 at 4:30 p.m. through July 13 at 5:00 p.m.
Be the first to comment on this post